Allison Wey
Senior Vice President, Investor Relations
Replay available
Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Shannon
Chairman and Chief Executive Officer
Steve Pieper
Chief Financial Officer
Georgia Bank
Analyst, Jefferies (for Dennis Ding)
Brandon Folks
Analyst, H.C. Wainwright
David Amsalem
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Xeris Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.417 Hello, everyone. Thank you for joining us and welcome to Xeris Biopharma 00:00:05.417 -- 00:00:10.563 Second Quarter Earnings Conference Call. After today's prepared remarks, we will 00:00:10.563 -- 00:00:15.728 host a question and answer session. If you would like to ask a question, please press 00:00:15.728 -- 00:00:21.194 star 1 to raise your hand. To withdraw your question, press star 00:00:21.194 -- 00:00:26.263 1 again. I will now hand the conference over to Allison Wey, 00:00:26.263 -- 00:00:29.205 Senior Vice President of Investor Relations. 00:00:29.205 -- 00:00:31.547 Allison, please go ahead. 00:00:31.547 -- 00:00:36.011 Thank you, Leah. Good morning, everyone, and welcome to Xeris Biopharma's second quarter 00:00:36.011 -- 00:00:40.675 financial results conference call. Early this morning, we issued a press release detailing 00:00:40.675 -- 00:00:44.378 our results. This press release can be found on our website. 00:00:44.378 -- 00:00:48.501 Joining me on today's call is John Shannon, our Chairman and Chief Executive Officer, 00:00:48.501 -- 00:00:51.618 and Steve Pieper, our Chief Financial Officer. 00:00:51.618 -- 00:00:55.839 Following our prepared remarks, we'll open the call for your questions. 00:00:55.839 -- 00:01:00.400 Before we begin, I'd like to remind you that today's discussion will include forward-looking 00:01:00.400 -- 00:01:05.641 statements regarding Xeris' future expectations, plans, strategies, objectives, 00:01:05.641 -- 00:01:10.122 and financial performance. These forward-looking statements are based on management's 00:01:10.122 -- 00:01:14.723 current assumptions and beliefs and are subject to a number of risks and uncertainties 00:01:14.723 -- 00:01:20.430 that could cause actual results to diff...